Semaglutide reverses one womans symptoms After moving to Colorado and finally being diagnosed by a nurse practitioner, Hamilton joined a clinical trial in October 2024 at the University of Colorado Anschutz evaluating semaglutide the popular diabetes-turned-weight-loss drug as a therapy for PMOS
These gastrointestinal symptoms typically occur when starting treatment or increasing the dose, as the medication slows gastric emptying and affects appetite-regulating areas of the brain
Holistic GLP-1 weight loss coach certification Step into a new era of wellness leadership
At our clinic in Doral, FL, we work almost exclusively in the superficial to light-medium range for acne, which is where the clinical benefit is real and the risk of post-inflammatory hyperpigmentation is manageable
doi: 10.18044/Medinform.202071.1088
Beneficial effects on liver steatosis in animal models are also observed with regard to other SGLT2 inhibitors such as luseoglifozin and ipraglifozin [101, 102]